Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02804048
Other study ID # 13-0307
Secondary ID
Status Completed
Phase N/A
First received February 12, 2016
Last updated October 4, 2016
Start date December 2012
Est. completion date October 2016

Study information

Verified date October 2016
Source Hospital de Clinicas de Porto Alegre
Contact n/a
Is FDA regulated No
Health authority Brazil: National Committee of Ethics in Research
Study type Interventional

Clinical Trial Summary

Aim: To evaluate the effectiveness of physical therapy intervention techniques in the improvement of dyspareunia in climacteric women.

Study design: This is a randomized controlled trial.


Description:

Search location: Menopause and Sexuality Clinic of the department of obstetrics and Gynecology and Clinical Research Center, Hospital de ClĂ­nicas de Porto Alegre (HCPA).

Patients or participants: The recruited patients may not be vaginal atrophy (cytology-hormone test) and must provide the diagnosis of dyspareunia for more than six months being confirmed by one of the investigators through the pain score above grade 3 (visual analog pain scale) visual inspection, palpation and a questionnaire about the duration and location of pain.

Intervention and measures: consist of evaluation of the pelvic floor muscles (Oxford Scale and Perfect), myoelectric assessment (Electromyography), quality of life (Cervantes Scale), sexual function (FSFI), level of depression (Beck Scale) and pain (visual analog pain scale) before and after physical therapy intervention.

Expected results: To estimate the effectiveness of pelvic floor training techniques with physical therapy in women with dyspareunia.


Recruitment information / eligibility

Status Completed
Enrollment 42
Est. completion date October 2016
Est. primary completion date September 2016
Accepts healthy volunteers No
Gender Female
Age group 40 Years to 60 Years
Eligibility Inclusion Criteria:

- dyspareunia complaint for at least six months

- visual analog scale of pain above 3

- trophic vagina

Exclusion Criteria:

- vaginal atrophy

- neurological disorders

- lack of cognition and understanding

- urinary tract infection and / or genital infections

- prolapse grade 2 and 3

- severe systemic disease

- performing physical therapy

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
superficial heat pelvic floor muscle
Superficial heat application in the pelvic floor muscle
superficial heat low back
Superficial heat application in the low back
Pelvic Floor Muscle Training
Pelvic floor muscle training exercises
Manual therapy in iliopsoas, diaphragm and piriformis
Manual therapy in iliopsoas, diaphragm and piriformis for 10 minutes
Intra Vaginal Manual therapy
Intra Vaginal Manual therapy in the pelvic floor muscles
Electromyographic biofeedback
Electromyographic biofeedback in the pelvic floor muscles

Locations

Country Name City State
Brazil Clinical Research Center of HCPA Porto Alegre RS

Sponsors (1)

Lead Sponsor Collaborator
Hospital de Clinicas de Porto Alegre

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary To evaluate the effectiveness of physiotherapy techniques in pain improvement using visual analog scale pain To evaluate the effectiveness of physiotherapy techniques using the analog pain scale. Seven meetings, twice a week, in which the first is the initial assessment and the seventh is the final evaluation totaling a maximum of one month treatment for each patient. Yes
Secondary To evaluate the quality of life To evaluate the quality of life, using Cervantes Scale in climateric women in baseline and after four weeks of intervention Yes
Secondary To evaluate depression To evaluate depression, using Beck Scale, in baseline and after four weeks of intervention Yes
Secondary To evaluate sexual function To evaluate sexual function, using Female Sexual Function Index, in baseline and after four weeks of intervention Yes
Secondary To evaluate electrical activity of the pelvic floor muscles To evaluate electrical activity of the pelvic floor muscles, using Electromyographic biofeedback , in baseline and after four weeks of intervention Yes
Secondary To evaluate the pelvic floor muscle function To evaluate the pelvic floor muscle function, using PERFECT Scale in baseline and after four weeks of intervention Yes
See also
  Status Clinical Trial Phase
Completed NCT03935698 - Physiotherapy Treatment in Women With Dyspareunia Following Gynecological Cancer: a Pilot Study N/A
Recruiting NCT03427255 - CBT Group Treatment for Women With Dyspareunia N/A
Completed NCT02253173 - Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women Phase 3
Completed NCT03184077 - Rapidly Absorbing Polyglactin 910 Versus Poliglecaprone 25 for Laceration Repair N/A
Recruiting NCT05445115 - The Mollie Study, a Study to Evaluate the Safety and Efficacy of the Mollie Medical Device N/A
Withdrawn NCT03666819 - Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy Phase 2
Active, not recruiting NCT03681678 - Laser Therapy for Treatment of Urogenital Symptoms in Women
Completed NCT04955418 - Effects of Epi-no Device on Pelvic Floor Dysfunctions N/A
Completed NCT05834088 - Effects of Myofascial Release With and Without Thiele Massage N/A
Terminated NCT03185169 - GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors Early Phase 1
Completed NCT03307044 - Fractional CO2 Laser Therapy for Survivors of Breast Malignancies N/A
Completed NCT05617820 - Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy Phase 3
Recruiting NCT03714581 - Laser Therapy Following Radiotherapy for Gynecological Cancer N/A
Completed NCT04659668 - Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of the Vagina. N/A
Completed NCT03199534 - A Trial of Pelvic Floor Chemodenervation in Patients Undergoing Physical Therapy for High Tone Pelvic Floor Dysfunction Phase 4
Completed NCT00318500 - Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women Phase 2
Recruiting NCT05540353 - Transvaginal Low-level Laser Therapy to Improve Pelvic Pain and Sexual Function in Patients With Endometriosis. N/A
Completed NCT03178825 - Hybrid Fractional Laser for Symptoms of Genitourinary Syndrome of Menopause N/A
Completed NCT04389489 - Postpartum Sexual Function in Pregnant Women With COVID-19
Completed NCT03372720 - Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors N/A